Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy (2015)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1136/heartjnl-2014-305864
- Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR); DOENÇAS CARDIOVASCULARES (TERAPIA); CUSTOS DOS CUIDADOS DE SAÚDE; CUSTOS DE MEDICAMENTOS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc
-
ABNT
JANZON, M. et al. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart, v. 101, n. 2, p. 119-125, 2015Tradução . . Disponível em: https://doi.org/10.1136/heartjnl-2014-305864. Acesso em: 01 jun. 2024. -
APA
Janzon, M., James, S., Cannon, C. P., Storey, R. F., Mellström, C., Nicolau, J. C., et al. (2015). Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart, 101( 2), 119-125. doi:10.1136/heartjnl-2014-305864 -
NLM
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy [Internet]. Heart. 2015 ; 101( 2): 119-125.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1136/heartjnl-2014-305864 -
Vancouver
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy [Internet]. Heart. 2015 ; 101( 2): 119-125.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1136/heartjnl-2014-305864 - Síndrome coronariana aguda com elevação do segmento St: tratamento medicamentoso
- Isquemia miocárdica como manifestação inicial de arterite de Takaysu
- Prasugrel, ticagrelor e antagonista do receptor da trombina nas síndromes isquêmicas miocárdicas instáveis com e sem supradesnível do segmento ST
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
- Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial
- Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome
- Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial
Informações sobre o DOI: 10.1136/heartjnl-2014-305864 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
